Papworth Trust joins Unity Campus
Howard Group provides local charity with an affordable and well-equipped
new home
Howard Group provides local charity with an affordable and well-equipped
new home
AMSBIO has expanded its biofluid collection and processing capabilities, to now offer an unmatched range of customizable human blood biospecimens from both healthy and disease-state donors to support biomedical research.
Leveraging an extensive network of diverse donors, AMSBIO provides high-quality, ethically sourced samples tailored to specific donor demographics, sample volumes, and processing methods.
Kadans Science Partner (“Kadans”), a leading European investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors, has commenced construction on its purpose-built laboratory facility, Versa.
As the second project to be delivered by Kadans within the Tileyard Quarter in King’s Cross, London, this is a significant milestone for both the area and London’s life science sector more generally.
Miltenyi Biotec, an innovator of products and services for biomedical research and cell and gene therapies, has announced a strategic partnership with leading developer of life science ecosystems, integrating infrastructure, investment, and venture support, Pioneer Group.
Read April eNews here 👉 https://shorturl.at/xZ6e9
Sponsored by Catalent Pharma Solutions
Featuring:
One Nucleus is always conscious that our member companies are constantly mindful of the need to be international given the nature of the life sciences sector, innovation and the unmet medical needs they seek to address.
London, April 1, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, is delighted to announce the strengthening of its management team with the promotion of Penny Sadler as Managing Partner.
Are you a pre-clinical therapeutics start-up?
Stevenage Bioscience Catalyst’s Catalyser is an accelerator designed to help businesses attract investors and partners, and maximise overall chances of commercial success.
The Triple Chasm framework is used to structure the programme via six interactive sessions on the below topics:
Where partnering becomes the science of connection
BIO-Europe is the largest, longest-running biopharma partnering conference in Europe. It has evolved with the biotech industry to deliver an efficient way for biotech and pharma companies to identify and build partnerships. Organized by EBD Group and supported by partneringONE, the conference is a forum for connection: though one-to-one meetings, and through the program, exhibit hall marketplace, evening receptions and interest group-focused wellness activities.
Webcast | 10:00-11:00
President Trump has stated that the next round of US tariffs will apply from 2 April, ‘liberation day’. Our rapid response webcast will assess the blueprint for these tariffs, the impact on UK businesses and the wider business environment.